Twenty Years of Insulin Gla-100: A Systematic Evaluation of Its Efficacy and Safety in Type 2 Diabetes Mellitus Bipin SethiA. G. UnnikrishnanAdlyne R. Asirvatham Review Open access 30 June 2022 Pages: 1409 - 1481
IDegLira for the Real-World Treatment of Type 2 Diabetes in Italy: Protocol and Interim Results from the REX Observational Study Gian Paolo FadiniRaffaella BuzzettiREX study group Original Research Open access 18 June 2022 Pages: 1483 - 1497
An Early Assessment of the Real-World Treatment Patterns of Type 2 Diabetes: A Comparison to the 2018 ADA/EASD Consensus Report Recommendations Jay P. BaeZbigniew A. KadziolaKieren J. Mather Original Research Open access 29 June 2022 Pages: 1499 - 1510
Practical Guidance on Basal Insulin Initiation and Titration in Asia: A Delphi-Based Consensus Siew Pheng ChanAzizul Hasan AamirNam Quang Tran Original Research Open access 29 June 2022 Pages: 1511 - 1529
Association Between the Tissue and Circulating Advanced Glycation End-Products and the Micro- and Macrovascular Complications in Type 1 Diabetes: The DIABAGE Study Alpha M. DialloStéphane JaissonBrigitte Delemer Original Research Open access 02 July 2022 Pages: 1531 - 1546
Efficacy and Safety of Ultra-Rapid Lispro in Younger and Older Patients with Type 2 Diabetes: Randomized Double-Blind PRONTO-T2D Study Qianyi ZhangFarai ChigutsaAnnette M. Chang Original Research Open access 04 July 2022 Pages: 1547 - 1557
Comparison of the Effectiveness of Once-Daily Alogliptin/Metformin and Twice-Daily Anagliptin/Metformin Combination Tablet in a Randomized, Parallel-Group, Open-Label Trial in Japanese Patients with Type 2 Diabetes Shunsuke YamazakiTatsuro TakanoYasuo Terauchi Original Research Open access 06 July 2022 Pages: 1559 - 1569
Correction to: The FIDELIO Study Podcast Robert TotoGeorge Bakris Correction Open access 02 July 2022 Pages: 1571 - 1571